Leaf Biotech Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
53
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$13.9M
- Investors
-
9
Leaf Biotech General Information
Description
Developer of the core monomer of bio-based new materials such as furandicarboxylic acid (FDCA) intended to assist in the development of a sustainable environment. The company develops new bio-based polyester material Polyethylene Furanoate (PEF) and its key intermediates, as well as green medicine and health care intermediates, providing sustainable biomass resources.
Contact Information
Website
www.leafbiotech.comCorporate Office
- Floor 8-9, Area A, E3 Building, Phase II, Innovation Industrial Park
- Intersection of Chuangxin Avenue and Yunfei Road, High-tech Zone
- Hefei, Anhui 230001
- China
Corporate Office
- Floor 8-9, Area A, E3 Building, Phase II, Innovation Industrial Park
- Intersection of Chuangxin Avenue and Yunfei Road, High-tech Zone
- Hefei, Anhui 230001
- China
Leaf Biotech Timeline
Leaf Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 17-Jul-2025 | $13.9M | Completed | Generating Revenue | ||
| 7. Secondary Transaction - Private | 27-Nov-2024 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 24-Jun-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 22-Dec-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 01-Jul-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 09-May-2017 | Completed | Generating Revenue | |||
| 2. Grant | 01-Nov-2016 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 23-Oct-2015 | Completed | Generating Revenue |
Leaf Biotech Patents
Leaf Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026199833-A1 | Method for preparing 2,5-furandicarboxylic acid | Pending | 24-Mar-2025 | ||
| JP-2026524574-A | Method and apparatus for preparing flanger carboxylic acid | Pending | 11-Jun-2024 | ||
| US-20250376454-A1 | Method and apparatus for preparing furan dicarboxylic acid | Pending | 11-Jun-2024 | ||
| EP-4692070-A1 | Method and device for preparing furandicarboxylic acid | Pending | 11-Jun-2024 | ||
| EP-4692070-A4 | Method and device for preparing furandicarboxylic acid | Pending | 11-Jun-2024 | C07D307/68 |
Leaf Biotech Signals
Leaf Biotech Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Xinfengming Group | Corporation | Minority | ||
| Anyuan Fund | Venture Capital | Minority | ||
| Chongqing Zehui Equity Investment Fund Management | Growth/Expansion | Minority | ||
| Ciit Asset Management | Asset Manager | Minority | ||
| Guanzi Private Equity Fund Management | Growth/Expansion | Minority |
Leaf Biotech Investments (1)
Leaf Biotech’s most recent deal was a Early Stage VC with Like Materials. The deal was made on 13-Feb-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Like Materials | 13-Feb-2023 | Early Stage VC | Specialty Chemicals |
Leaf Biotech FAQs
-
When was Leaf Biotech founded?
Leaf Biotech was founded in 2014.
-
Where is Leaf Biotech headquartered?
Leaf Biotech is headquartered in Hefei, China.
-
What is the size of Leaf Biotech?
Leaf Biotech has 53 total employees.
-
What industry is Leaf Biotech in?
Leaf Biotech’s primary industry is Specialty Chemicals.
-
Is Leaf Biotech a private or public company?
Leaf Biotech is a Private company.
-
What is the current valuation of Leaf Biotech?
The current valuation of Leaf Biotech is .
-
What is Leaf Biotech’s current revenue?
The current revenue for Leaf Biotech is .
-
How much funding has Leaf Biotech raised over time?
Leaf Biotech has raised $42M.
-
Who are Leaf Biotech’s investors?
Xinfengming Group, Anyuan Fund, Chongqing Zehui Equity Investment Fund Management, Ciit Asset Management, and Guanzi Private Equity Fund Management are 5 of 9 investors who have invested in Leaf Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process